NCT06535867 The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
| NCT ID | NCT06535867 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Condition | Smoking |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,122 participants |
| Start Date | 2024-07-30 |
| Primary Completion | 2031-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,122 participants in total. It began in 2024-07-30 with a primary completion date of 2031-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Mobile health (mHealth) will be used for early detection of oral cancer and pre-cancer lesions, and to improve awareness of oral cancer among the population and knowledge of oral cancer diagnosis among frontline health providers. This program is inclusive of long term surveillance to downstage oral cancer in India
Eligibility Criteria
Inclusion Criteria: Positive for any one or more of the following: * All individuals aged above 18 years positive for habits (smoking and smokeless tobacco, chewing betel leaf, areca nut, paan masala, and/or regular use of alcohol) * Clinical signs/symptoms (non-healing ulcers, white/ red/red \& white patches in the mouth, restriction of mouth opening and swelling of the neck) * All individuals aged above 40 irrespective of habit/oral lesions Exclusion Criteria: * Individuals already diagnosed with oral cancer and undergoing treatment for oral cancer * Under treatment for tuberculosis or suffering from any acute illness/ debilitating systemic disorders
Contact & Investigator
Milind Rajadhyaksha, PhD
PRINCIPAL INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Frequently Asked Questions
Who can join the NCT06535867 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06535867 currently recruiting?
Yes, NCT06535867 is actively recruiting participants. Contact the research team at rajadhym@mskcc.org for enrollment information.
Where is the NCT06535867 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06535867 clinical trial?
NCT06535867 is sponsored by Memorial Sloan Kettering Cancer Center. The principal investigator is Milind Rajadhyaksha, PhD at Memorial Sloan Kettering Cancer Center. The trial plans to enroll 5,122 participants.